Table 1.
Bilateral placement of TEs in a nonhuman primate model, with or without coverage by HADM
| Animal ID | Placement | Implant condition |
|---|---|---|
| 02703 | Left | TE-only |
| Right | TE + AM | |
| N993 | Left | TE-only |
| Right | TE + AM | |
| 04099 | Left | TE-only |
| Right | TE + AM | |
| 01659 | Left | TE-only |
| Right | TE + AD | |
| 08247 | Left | TE-only |
| Right | TE + AD | |
| 07655 | Left | TE-only |
| Right | TE + AD | |
| 07656 | Left | TE + AM |
| Right | TE + AD | |
| 07654 | Left | TE + AM |
| Right | TE + AD | |
| 07657 | Left | TE + AM |
| Right | TE + AD |
Treatment groups included tissue expander (TE)-only, TE + non–gamma-irradiated human acellular dermal matrix (HADM) (AlloDerm; AD), and TE + gamma-irradiated HADM (AlloMax; AM).